Researchers hunt for best test to spot hidden hormone problem in adrenal tumors
NCT ID NCT06344143
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at 20 adults with adrenal tumors (incidentalomas) to find the most accurate tests for detecting mild autonomous cortisol secretion (MACS), a condition where the tumor releases extra cortisol. Participants will provide blood, saliva, and urine samples and undergo several stimulation tests. Researchers will track them for 4 years to see if their condition changes, aiming to improve diagnosis and understanding of this hormone imbalance.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADRENAL INCIDENTALOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Cleveland Clinic Foundation
RECRUITINGCleveland, Ohio, 44195, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a drug tame excess cortisol in a common hormone disorder?
- Can a diabetes drug fix lingering health issues after adrenal surgery?
- Can a diabetes drug replace surgery for a rare hormone disorder?
- Could a simple saliva test replace blood draws for cortisol screening?
- Urine test could replace repeated scans for adrenal tumors
- Drug showdown: which pill tames cortisol better?